Skip to main content
. 2018 Nov 19;42(1):157–163. doi: 10.2337/dc18-1144

Table 3.

Increased risk of cardiovascular events and mortality associated with severe hypoglycemia within the prior 3 months

All participants*
Standard treatment group only Intensive treatment group only
HR (95% CI) P value HR (95% CI) HR (95% CI) P value for interaction effect by treatment group
Cardiovascular event 1.9 (1.06, 3.52) 0.032 2.50 (1.0, 6.1) 1.7 (0.75, 3.83) >0.2
Cardiovascular mortality 3.7 (1.3, 10.4) 0.012 8.6 (1.9, 37.7) 2.1 (0.51, 8.9) 0.184
All-cause mortality 2.4 (1.1, 5.1) 0.024 6.7 (2.7, 16.6) 0.92 (0.23, 3.8) 0.019

*Adjusted for treatment group, cardiovascular risk (as estimated by UKPDS score), history of cardiovascular event, insulin at baseline, and eGFR.